Evidence map›Paper›PMID 24296302›Full record

ArticleToxicology and applied pharmacology2014

Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile.

Dawit Melak, Catterina Ferreccio, David Kalman, Roxana Parra, Johanna Acevedo, Liliana Pérez, Sandra Cortés, Allan H Smith, Yan Yuan, Jane Liaw and 1 more

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 6 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 6 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Arsenic Exposure and Risk of Urothelial Cancer: Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  5. Pooled it
  6. Factors Affecting Arsenic Methylation in Arsenic-Exposed Humans: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2016
    Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Speciation of Arsenic in Medium Containing Bacterial Strains ofInternational journal of environmental research and public health · 2025
    Article
  11. Article
  12. Risk Factors Associated with Urothelial Bladder Cancer.International journal of environmental research and public health · 2024
    Review
  13. Review
  14. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  15. Article
  16. Arsenic and cancer: Evidence and mechanisms.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Dawit MelakGlobal Health Sciences, University of California, San Francisco, San Francisco, CA, USA.
Catterina FerreccioEscuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
David KalmanSchool of Public Health and Community Medicine, University of Washington, Seattle, WA, USA.
Roxana ParraHospital Regional de Antofagasta, Antofagasta, Chile.
Johanna AcevedoEscuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Liliana PérezEscuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Sandra CortésEscuela de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Allan H SmithArsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Yan YuanArsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Jane LiawArsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Craig SteinmausArsenic Health Effects Research Group, School of Public Health, University of California, Berkeley, Berkeley, CA, USA; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA, USA. Electronic address: craigs@berkeley.edu.
Pontificia Universidad Católica de Chile · CLUniversity of California, Berkeley · USBerkeley Public Health Division · USHospital Regional de Antofagasta · CLUniversity of California, San Francisco · USUniversity of Washington · US

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MORELLO-FROSCH, RACHEL ADELE · 1987 to 2025
$74.6M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Incident cancer studies in a unique arsenic-exposed area of ChileR01ES014032 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI STEINMAUS, CRAIG M · 2007 to 2018
$3.8M
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteinsR01ES021100 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HUDSON, LAURIE G, LIU, KE JIAN · 2012 to 2016
$2.4M
Arsenic-enhanced skin carcinogenesis by UV radiationR01ES015826 · NIEHS · UNIVERSITY OF NEW MEXICO · PI LIU, KE JIAN · 2007 to 2011
$2.3M
PERCHLORATE AND THYROID HORMONES IN PREGNANCY AND INFANTS IN SOUTHERN CALIFORNIAR01ES020365 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI STEINMAUS, CRAIG M · 2011 to 2014
$2.1M
NCI NIH HHS P30CA118100NIEHS NIH HHS P42 ES004705NIEHS NIH HHS R01 ES014032NIEHS NIH HHS R01 ES020365NIEHS NIH HHS R01ES021100NIEHS NIH HHS R01ES15826NIEHS NIH HHS R01ES15826-03S1
6 · The paper itself

Abstract

In humans, ingested inorganic arsenic is metabolized to monomethylarsenic (MMA) then to dimethylarsenic (DMA), although this process is not complete in most people. The trivalent form of MMA is highly toxic in vitro and previous studies have identified associations between the proportion of urinary arsenic as MMA (%MMA) and several arsenic-related diseases. To date, however, relatively little is known about its role in lung cancer, the most common cause of arsenic-related death, or about its impacts on people drinking water with lower arsenic concentrations (e.g., <200μg/L). In this study, urinary arsenic metabolites were measured in 94 lung and 117 bladder cancer cases and 347 population-based controls from areas in northern Chile with a wide range of drinking water arsenic concentrations. Lung cancer odds ratios adjusted for age, sex, and smoking by increasing tertiles of %MMA were 1.00, 1.91 (95% confidence interval (CI), 0.99-3.67), and 3.26 (1.76-6.04) (p-trend <0.001). Corresponding odds ratios for bladder cancer were 1.00, 1.81 (1.06-3.11), and 2.02 (1.15-3.54) (p-trend <0.001). In analyses confined to subjects only with arsenic water concentrations <200μg/L (median=60μg/L), lung and bladder cancer odds ratios for subjects in the upper tertile of %MMA compared to subjects in the lower two tertiles were 2.48 (1.08-5.68) and 2.37 (1.01-5.57), respectively. Overall, these findings provide evidence that inter-individual differences in arsenic metabolism may be an important risk factor for arsenic-related lung cancer, and may play a role in cancer risks among people exposed to relatively low arsenic water concentrations.

Indexed as

AgedArsenicCase-Control StudiesChileDrinking WaterFemaleHumansLung NeoplasmsMaleMethylationMiddle AgedOdds RatioRisk FactorsSurveys and QuestionnairesUrinary Bladder NeoplasmsWater PollutantsArsenicDrinking WaterWater PollutantsArsenicBladderCancerLungMethylationWater

Identifiers

PMID24296302
PMCPMC4344188
OpenAlexW2019825989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.